Age at initiation of cannabis use predicts age at onset of psychosis: The 7-to 8-year trend

Schizophrenia Bulletin

Volumn 39, Issue 2, 2013, Pages 251-254

  Stefanis, Nikos C ^a,b   Dragovic, Milan ^a,b   Power, Brian D ^c   Jablensky, Assen ^a   Castle, David ^d   Morgan, Vera Anne ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b North Metropolitan Area Health Service   (Australia)

^c South Metropolitan Area Health Service   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

age at onset; cannabis; causality; DIP; psychosis; schizophrenia; SHIP

Indexed keywords

CANNABIS;

ADULT; ARTICLE; AUSTRALIA; CANNABIS ADDICTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY HISTORY; FEMALE; HUMAN; LIFESPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; TREND STUDY;

EID: 84874547608     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbs188     Document Type: Article

References (20)

1. Large M, Sharma S, Compton MT, Slade T, Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry. 2011;68:555-561.
2. Barnett JH, Werners U, Secher SM, et al. Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry. 2007;190:515-520. (Pubitemid 46868836)
3. Leeson VC, Harrison I, Ron MA, Barnes TR, Joyce EM. The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia. Schizophr Bull. 2012;38:873-880.
4. Galvez-Buccollini JA, Proal AC, Tomaselli V, et al. Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis. Schizophr Res. 2012;139:157-160.
5. Estrada G, FatjVilas M, Muz MJ, et al. Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatr Scand. 2011;123:485-492.
6. Morgan VA, Waterreus A, Jablensky A, et al. People living with psychotic illness in 2010: the second Australian national survey of psychosis. Aust N Z J Psychiatry. 2012;46:735-752.
7. Moore E, Mancuso SG, Slade T, Galletly C, Castle DJ. The impact of alcohol and illicit drugs on people with psychosis: the second Australian national survey of psychosis. Aust N Z J Psychiatry. 2012;46:864-878.
8. Castle DJ, Jablensky A, McGrath JJ, et al. The diagnostic interview for psychoses (DIP): development, reliability and applications. Psychol Med. 2006;36:69-80. (Pubitemid 41825347)
9. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry. 1991;48:764-770.
10. Miller GA, Chapman JP. Misunderstanding analysis of covariance. J Abnorm Psychol. 2001;110:40-48. (Pubitemid 32205156)
11. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325:1212-1213. (Pubitemid 35398785)
12. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ. 2002;325:1199.
13. McGrath J, Welham J, Scott J, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010;67:440-447.
14. Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, Van Os J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction. 2004;99:1333-1341. (Pubitemid 39330938)
15. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med. 2003;33:15-21. (Pubitemid 36113396)
16. Schubart CD, van Gastel WA, Breetvelt EJ, et al. Cannabis use at a young age is associated with psychotic experiences. Psychol Med. 2010;7:1-10
17. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370:319-328. (Pubitemid 47094993)
18. Kuepper R, van Os J, Lieb R, Wittchen HU, Hler M, Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ. 2011;342:d738. doi:10.1136/bmj.d738.
19. van Os J, Kenis G, Rutten BP. The environment and schizophrenia. Nature. 2010;468:203-212.
20. Investigators Group. Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis: an analysis of patient-sibling and sibling-control pairs. Arch Gen Psychiatr. 2011;68:138-147.